7631 - 7640 of 9039 Results
Title
Year
- The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease2018OPENTitle: The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 171End Page: 176Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12591Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12591Citation Count: 67
- Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide2020OPENTitle: Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and SafinamideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 343End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12921Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/134126Citation Count: 338
-
OPENTitle: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 19Start Page: 1944End Page: 1950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9aBest OA location URL: https://n.neurology.org/content/neurology/79/19/1944.full.pdfCitation Count: 155
- Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)2020RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 1
-
OPENTitle: ggtranscript : an R package for the visualization and interpretation of transcript isoforms using ggplot2Journal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 38Issue #: 15Start Page: 3844End Page: 3846Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bioinformatics/btac409Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/38/15/3844/49884398/btac409.pdfCitation Count: 726
-
OPENTitle: The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell linesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page: 773End Page: 789Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddac233Best OA location URL: https://academic.oup.com/hmg/article-pdf/32/5/773/49283269/ddac233.pdfCitation Count: 13
-
OPENTitle: The effects of mood and cognition on daily functioning and quality of life in older people living with HIV and people with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 35Issue #: 7Start Page: 691End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000760Best OA location URL: https://doi.org/10.1037/neu0000760Citation Count: 3
- Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.2022RESTRICTEDTitle: Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 4Start Page: 266End Page: 278Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000795Citation Count: 5
-
OPENTitle: Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammationJournal Name: Mucosal ImmunologyPublisher: Elsevier BVVol: 14Issue #: 3Start Page: 652End Page: 666Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41385-020-00354-7Best OA location URL: https://www.nature.com/articles/s41385-020-00354-7.pdfCitation Count: 40
- Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease2022OPENTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 24